Seth Loring Harrison, Director, 10% Owner at Tokai Pharmaceuticals Inc (TKAI), bought 7,912,070 shares at $15.00 ($5.4M) on 2014-09-22, disclosed to the SEC on 2014-09-24.
Open-market purchase of $5.4M TKAI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,549,570 | $0 | 0.0% |
| 2 | $15.00 | 362,500 | $5.4M | 100.0% |
| Total | $0.69 avg | 7,912,070 | $5.4M | 100% |
| Filing → |
| AKRO | SELL | 2022-10-27 | $24.4M | — | Filing → |
| STOK | BUY | 2020-11-25 | $14.6M | — | Filing → |
| AKRO | BUY | 2020-07-14 | $14.9M | — | Filing → |